Intercept Pharmaceuticals, Inc. Debt to Equity Ratio 2013-2023 | ICPT

Current and historical debt to equity ratio values for Intercept Pharmaceuticals, Inc. (ICPT) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Intercept Pharmaceuticals, Inc. debt/equity for the three months ending September 30, 2023 was .
Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2023-09-30 $0.32B $0.07B 4.47
2023-06-30 $0.42B $0.07B 6.18
2023-03-31 $0.44B $0.07B 6.50
2022-12-31 $0.46B $0.09B 4.95
2022-09-30 $0.45B $0.11B 4.20
2022-06-30 $0.87B $-0.37B -2.35
2022-03-31 $0.88B $-0.37B -2.35
2021-12-31 $0.71B $-0.18B -3.87
2021-09-30 $0.68B $-0.16B -4.35
2021-06-30 $0.73B $-0.20B -3.58
2021-03-31 $0.72B $-0.20B -3.60
2020-12-31 $0.75B $-0.17B -4.48
2020-09-30 $0.72B $-0.13B -5.54
2020-06-30 $0.72B $-0.08B -9.09
2020-03-31 $0.70B $-0.04B -20.08
2019-12-31 $0.70B $0.05B 13.64
2019-09-30 $0.67B $0.13B 5.14
2019-06-30 $0.68B $0.18B 3.87
2019-03-31 $0.49B $-0.06B -8.97
2018-12-31 $0.49B $0.02B 25.62
2018-09-30 $0.46B $0.10B 4.81
2018-06-30 $0.46B $0.15B 3.13
2018-03-31 $0.45B $-0.05B -8.53
2017-12-31 $0.47B $0.02B 28.56
2017-09-30 $0.45B $0.11B 4.02
2017-06-30 $0.45B $0.17B 2.63
2017-03-31 $0.43B $0.24B 1.78
2016-12-31 $0.42B $0.32B 1.35
2016-09-30 $0.40B $0.42B 0.96
2016-06-30 $0.11B $0.42B 0.26
2016-03-31 $0.11B $0.49B 0.22
2015-12-31 $0.05B $0.60B 0.09
2015-09-30 $0.04B $0.68B 0.06
2015-06-30 $0.03B $0.72B 0.04
2015-03-31 $0.03B $0.40B 0.07
2014-12-31 $0.02B $0.23B 0.10
2014-09-30 $0.03B $0.26B 0.10
2014-06-30 $0.02B $0.29B 0.07
2014-03-31 $0.30B $-0.15B -1.92
2013-12-31 $0.07B $0.08B 0.82
2013-09-30 $0.07B $0.09B 0.75
2013-06-30 $0.05B $0.12B 0.41
2013-03-31 $0.05B $0.06B 0.75
2012-12-31 $0.05B $0.07B 0.70
2012-09-30 $0.00B 0.00
2012-06-30 $0.00B 0.00
2012-03-31 $0.00B 0.00